Our annual INVEST conference, where investors and startups meet, kicks off today as a virtual event. Rather than a day and a half in-person event, MedCity will highlight the seismic changes in healthcare today through Friday, July 24. Healthcare innovators from health systems and other segments of healthcare will share how they are facing the challenge of delivering care in a pandemic, what they have learned and how they are applying insight aggregated from their own institutions and colleagues at other organizations.
To register for the conference, click below:
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
Once you have registered, check your inbox for an email from Eventbrite with a link and your login credentials.
Today, at 12:30 pm ET, Christopher Coburn, chief innovation officer of Mass General Brigham, formerly Partners HealthCare, will open the conference. He will share how his nonprofit institution geared up to meet the challenge of Covid-19 and some of the major changes it implemented.
Next, starting at 3:30 pm, we will have five health service startups pitch in the first track of the INVEST Pitch Perfect competition. They include:
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Atentiv: Provider of proprietary clinically validated digital therapeutics that remediate the underlying cause of chronic behavioral disorders/ADHD – executive skills dysfunction – for health, success in school, home and life.
CEO: Eric Gordon
Headquarters: Waltham, MA
Hoy Health is a health technology platform that offers affordable and accessible primary healthcare to any consumer across 6 countries without the need of health insurance.
CEO: Mario Anglada
Headquarters: Morristown, NJ
Musical Health Technologies is a digital therapeutics company using proven, evidence-based singing therapies (from Harvard Medical School and McGill University, among others) to help hundreds of millions of people with neurological, hypertension, physical, pulmonary, and dementia challenges.
CEO: Rachel Francine
Headquarters: Los Angeles, CA
Univfy is the only AI platform in the fertility market that provides scientifically validated, personalized reports that counsel patients from diverse demographics about their probability of having a baby.
CEO: Mylene Yao
Headquarters: Los Altos, CA
Vivid Genomics develops tools to identify patient variation with neurodegenerative diseases to support and improve clinical trial design and analysis, enabling pharma companies to select and stratify the right patients for their clinical trials, increasing the probability of trial success and drug approval.
CEO: Julie Collens
Headquarters: San Diego, CA
The judges for the Health Services track include:
Ian Chiang, Principal, Flare Capital Partners
Adam Dakin, Managing Director, Dreamit Ventures
Dipa Mehta, VP, Corporate Ventures and Innovation, Advocate Aurora Health
Follow the hashtag #mcINVEST for tweets and coverage from the event.
Photo: Joshua Blake, Getty Images
